Catalyst Wire Dossier Catalyst Wire Dossier

GSK Bio CMV Vaccine

cytomegalovirus vaccine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSK Bio CMV Vaccine, covering 2017-05-30 to 2017-05-30. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Safety and Immunogenicity of the GSK Bio CMV Vaccine in CMV-seronegative Healthy Male Adult Subjects [Phase 1]

See pricing